Ivy is taking part in the five-year double-blind placebo controlled trial, meaning she doesn't know if she got the drug or ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
Pete Doherty has been told by doctors that he could 'lose' his toes amid his battle with type 2 diabetes. The Libertines ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Man, 52, ‘cured’ of his 15-year cocaine habit after taking weight loss jab in first case of its kind
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results